QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kodak-and-ateios-announces-it-has-demonstrated-the-fastest-solvent-free-production-process-for-high-energy-electrodes-ever-reported-ateios--backed-by-350k-grant-from-the-nsf-energy-storage-engine-in-new-york-for-pfas-free-96-reduction-in-energy-consumption

80 m/min RaiCure™ platform delivers higher energy, lower cost, near-zero toxic emission, no forever chemicalsAteios Systems and...

 eastman-kodak-q2-eps-036-down-from-023-yoy-sales-263000m-down-from-267000m-yoy

Eastman Kodak (NYSE:KODK) reported quarterly losses of $(0.36) per share. This is a 256.52 percent decrease over earnings of $0...

 kodak-posts-on-x-kodak-is-expanding-in-pharma-with-a-new-fda-registered-cgmp-facility-in-roc-producing-critical-components--reagents-for-medical-testing-shares-spike-higher

https://x.com/Kodak/status/1942666252725403839

 kodak-kodk-stock-falls-16-after-disappointing-q1-earnings

Kodak shares dropped 16% on Friday. The stock is lower following a weaker-than-expected Q1 earnings report.

 eastman-kodak-q1-eps-012-down-from-030-yoy-sales-24700m-down-from-24900m-yoy

Eastman Kodak (NYSE:KODK) reported quarterly losses of $(0.12) per share. This is a 140 percent decrease over earnings of $0.30...

 eastman-kodak-q4-eps-023-up-from-003-yoy-sales-26600m-down-from-27500m-yoy

Eastman Kodak (NYSE:KODK) reported quarterly earnings of $0.23 per share. This is a 666.67 percent increase over earnings of $0...

 eastman-kodak-q4-sales-266000m-down-from-275000m-yoy

Eastman Kodak (NYSE:KODK) reported $266.000 million in sales this quarter. This is a 3.27 percent decrease over sales of $275.0...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION